Recovery quality
Conditions
Interventions
Group C:total intravenous anesthesia based on cipropol:Anesthesia was induced with cyclopropofol 0.4 mg/kg (with supplemental doses of 0.2 mg/kg as needed), sufentanil 0.4 ug/kg, and cisatracurium 0.2
Group P:total intravenous anesthesia based on propofol:For anesthesia induction, propofol 2mg/kg was administered (with an optional supplemental dose of 1mg/kg if needed), followed by sufentanil 0.4ug
Sponsors
Nanjing Stomatological hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients undergoing elective oral and maxillofacial surgery under general anesthesia with an expected surgery duration of <= 2 hours; (2) Patients willing to undergo total intravenous anesthesia; (3) Patients aged 18-65 years with a BMI of 18-30 kg/m^2 and classified as ASA I-III; (4) Patients with no surgical history in the past three months; (5) Patients and their family members agree to sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with allergies to the anesthetic drugs or soybeans used in this study; (2) Patients with a history of alcohol, sedatives, analgesics, psychoactive drug abuse, or addiction; (3) Patients with organ dysfunction, arrhythmias, or congenital heart disease; (4) Patients with severe airway obstruction, such as sleep apnea syndrome or craniofacial syndromes; (5) Patients with severe visual or auditory impairments, or difficulties in communication; (6) Patients undergoing emergency surgery or surgery during pregnancy; (7) Patients who refuse to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QoR-15 score 24 hours post-surgery;Incidence of hypotension during induction and maintaince period; | — |
Secondary
| Measure | Time frame |
|---|---|
| QoR-15 score 48 hours post-surgery;The number of administrations and the total amount of vasoactive drugs;Time to lost of consciousness;Length of hospital sta;Recovery time and extubation time;Adverse events;The number of additional drug administrations; | — |
Countries
China
Contacts
Public ContactBao-jian Zhao
Nanjing Stomatological hospital
Outcome results
None listed